The Science of Clinical Research
Cliantha Research proudly announces the showcasing of its scientific activities and experience on its blog.
Cliantha Research is a global CRO dedicated to applying good science and research integrity into the development of much needed medications. Here in our blog, we will share our insights from our considerable experience in clinical research at all phases of clinical development.
Topics Covered & Coming Soon…
- Innovative Approaches for Innovative Drugs
i) Phase III Clinical Trial on Allergic Conjunctivitis performed in an Environmental Exposure Chamber
ii) Nasal Spray Fentanyl for Break Through Cancer Pain: A Question of Bioavailability in Patients with Rhinitis
iii) Non-Allergic Rhinitis: Provocateurs of Disease other than Allergens
iv) Dry Eye Disease & Contact Lens-Induced Dry Eye: The controlled study of changes in the lens and ocular surface in a low humidity environment - Accelerated Phase I
- Fast-To-File Approaches
- A First-To-File Approach: A Case Study
- The Cliantha Approach to Clinical Equivalence Trials = North America + India
- When Bigger is Not Better – Why a mid-sized CRO is better for small to medium sized Biotechs
DR. ANNE MARIE SALAPATEK
Executive VP & Chief Science Officer
asalapatek@cliantha.com